Billy Cho, Zai Lab CFO (Zai Lab)
April 21, 2022 11:16 AM EDT
Financing
China

Fol­low­ing BeiGene, Zai Lab changes au­di­tors amidst SEC threat of delist­ing

Paul Schloesser

Associate Editor

In a move to com­ply with new US pol­i­cy, Zai Lab an­nounced Thurs­day that it was se­lect­ing KP­MG as its new ac­count­ing firm, drop­ping the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Mer­ck buys in­to PD-1/VEGF space as Sum­mit comes for Keytru­da

BeiGene will re­brand to BeOne Med­i­cines, drop­ping name's link to Chi­na roots

Ex­clu­sive: As­cid­i­an CEO Michael Ehlers leaves Ap­ple Tree Part­ners for MPM BioIm­pact

FDA ap­proves PTC’s ul­tra-rare dis­ease gene ther­a­py for broad­er pa­tient pop­u­la­tion than Eu­rope

GSK makes case for Blenrep's re­turn with new blood can­cer sur­vival da­ta

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times